Kiwifruit Journal Articles

RSS Feed

Category: Technical

Running a trial: How hard can it be?

Running a trial: How hard can it be?

by Bill Snelgar - Plant & Food Research and Shane Max - Zespri

Your trial is valuable

Research trials are about learning so you need to believe your data, even if the trial does not show what you hoped. Carrying out a ‘rough’ comparison then discarding the results you don’t like - “the rows must have been different!” - but keeping those that fit your theory is a waste of time. You are only confirming your prejudices - you are not learning anything new.
Orchardists and scientists generally carry out trials to see if they can improve the productivity and, therefore, the profit of an orchard. This means the outcomes can be of huge value, and any errors can be costly.
Reaching a wrong conclusion can:
•    Add needless cost, by encouraging you to use a product or technique that does not work;
•    Lose money by not using a product or technique that does work.
With the payment structure used in the kiwifruit industry, even small increases in fruit size or fruit dry matter can give large increases in orchard gate return (OGR) (see Photo 1). For a Hayward orchard carrying 10,000 trays of fruit, we estimate that:
•    1 percent dry matter (0.15 TZG) is worth about $3,700/ha;
•    3g fresh weight (1 count size) is worth about $2,500/ha.
It is not easy to carry out trials that will always give you the correct answer when differences are this small. To avoid costly mistakes, a trial usually needs:
•    A control – where no treatment is applied so that you can see exactly what your treatment has changed;
•    Replication – to give some idea of the inherent variation among vines/fruit. Replication makes calculation of error possible;
Photo 1. If this spray increases the size of these (Green14) fruit by 3g, it’ll be worth about $3,000/ha, but it costs about $1200/ha to apply it. You really need to know if it works or not.
•    Randomisation – to avoid treatment bias and ensure that effects unknown to the experimenter are averaged out for each treatment.

Control

In a trial, you will want to see what changes are caused by your treatment so you need the control vines to be very similar to your treated vines to start with. Control vines should not be:
•    Your best row or block;
•    The shelter row;
•    The odd-shaped block in the corner;
•    Your neighbour’s orchard;
•    Last year’s crop.
Using good controls can actually help you a great deal when assessing the value of a treatment. For instance, Figure 1 shows the results of a trial where two alternative chemicals were compared with Hi-Cane®. The results look very promising, with the alternatives producing more than 11,000 trays/ha. Most orchardists would be very
happy with these new products. However, this trial also had a control where vines were not sprayed with anything. These vines yielded over 10,000 trays/ha. With this additional information, you’d probably decide that although all chemicals did increase yield, basic orchard management was the dominant factor producing the high yields in this orchard.

Replication and pseudo-replication

This is one of the hardest things to grasp - if you spray 10 vines in an orchard row, why don’t you have 10 replicates? The answer lies in the number of decisions you make about the trial layout. If you spray one row and leave another unsprayed,
you have made one decision and have one replicate of each treatment (Figure 2-A). This design is not statistically analysable and may well be misleading, since the two rows may be slightly different anyway - especially if one row is a shelter row. You are probably better off not doing this trial. In version B (Figure 2-B), at least the Figure 1. Results of a spray trial showing the yield of Hayward after vines had been sprayed with Hi-Cane®, or with alternative chemicals.

Randomise

The aim is to make sure you spread the treatments around the block randomly but without giving yourself the chance to bias the layout by choosing where treatments go. It is a good idea to select the vines for your trial carefully and reject those in poor condition or in badly-performing areas of the orchard.
For instance, if you are worried that the north end of the block may crop better than the southern end, then make sure you tag equal numbers of vines in each end but then randomly assign treatments within each half of the block. You can see in Figure 2-C, we have made sure there are three replicates of each treatment in the north end of the block and three in the southern end.
It is tempting simply to treat every second vine but this can lead to bias if there are gradients in productivity along the block. Randomising is the safest way to lay out a trial, plus it is easy. If you have only two treatments, flipping a coin is the quickest way. With more treatments, you may want to roll a dice.
treatments are spread across both rows, so bias should be reduced, but there are only two replicates and any difference is unlikely to be statistically detectable. Layout C is the one we’d use in a scientific trial. From the pattern of colours, it is obvious that treatments have been allocated to each vine one by one. The unit of replication is the item to which the treatment is applied individually – so individual vines are much better than rows or part-rows here. One glance at layouts A and B tells you they have poor replication and you should be very sceptical of any findings from such a trial.
Pseudo-replication is the term used when someone analyses the layout in
Figure 2-A and claims that they have 10 replicates. Analyses of this type are entirely unacceptable and are likely to be highly misleading. But it happens. Be very worried when someone says the trial was not properly randomised but we analysed it anyway. Statistics: making your analyses objective
Orchards and vines are not all identical so any time we measure attributes like fruit size and dry matter, we will usually see that some vines, or blocks, are better than others.
In our trials, we have found that the average dry matter of fruit typically varies by about 1 percent between vines. This variation can easily hide a good result, while a poor trial layout may also throw up large differences that are simply due to the between- vine variation we expect in any block. Statistics are the only way of deciding if the difference you see is due to the treatment you applied - or merely from chance variation. Even statistical analyses are not infallible. It is conventional to accept a difference as ‘significant’ if the probability of the difference occurring by chance is 1 in 20 (often referred to as P=0.05). That means that if you test 20 treatment comparisons, you are likely to obtain one ‘significant’ difference just by chance.
If run correctly, simple ‘on orchard’ trials have the ability to increase our knowledge rapidly, and cheaply. There are a number of resources to help growers and technical staff to undertake and analyse trials, including a series of KiwiTech Bulletins developed by Plant & Food Research on this topic. If you are unfamiliar with setting up trials, you are encouraged to discuss your idea with one of the team from Zespri’s Orchard Productivity Centre or with a friendly scientist. This should not only include how to set up the trial up but also how to measure and analyse the effects.

Avoiding resistance development to copper and antibiotics

Avoiding resistance development to copper and
antibiotics while controlling Psa

by Joel L. Vanneste - Plant & Food Research

One of the questions raised during last year’s Psa 2013 conference was: How can we ensure Psa will not become resistant to the copper based products and antibiotics we used for its control? In this article, we look at the precautions and strategies that can reduce the risk of selecting strains of the pathogen resistant to those products. Those strategies and precautions are relatively
simple; they consist of using antibiotics and copper in combination and in alternation, and to keep the populations of the pathogen as low as possible using other products and maintaining strict orchard hygiene. A coordinated control strategy applied on a large scale will also help in reducing the probability of selecting strains of the pathogen that are antibiotic resistant.

Whether bacterial pathogens attack plants, animals or humans, few products are available for their control. Most of these products are antibiotics or heavy metals. One of the most common concerns about using these products is the risk of selecting strains of the pathogens which are resistant to one or more of them. In the worst case scenario, resistance to antibiotics could spread from bacterium to bacterium, until it prevents us from controlling human pathogens that are today easily controlled, turning them into lethal pathogens.
In New Zealand, two antibiotics - streptomycin (KeyStreptoTM) and kasugamycin (KasuminTM) - have been allowed for the control of Pseudomonas syringae pv. actinidiae (Psa). Resistance to these two antibiotics as well as to copper, a heavy metal also used for the control of Psa, has been documented in a number of plant pathogenic bacteria.
A bacterium can become resistant to an antibiotic for different reasons. The antibiotic is being inactivated, its target has been modified, or the bacterium prevents it from entering the cell or exports it outside the cell. These different mechanisms can lead to either complete or partial resistance. For example, streptomycin kills bacteria by binding to the ribosome, a very complex structure necessary for protein synthesis. If the ribosome is modified
such that streptomycin cannot bind to it, then no amount of this antibiotic will kill the bacterium. The resistance is complete. On the other hand, if streptomycin is being modified by an enzyme, by increasing the concentration of streptomycin we can overload the enzyme and kill the bacterium. This partial resistance is also called reduced susceptibility or tolerance.
Resistance to antibiotics can result from a spontaneous mutation, or from the acquisition of a gene or a set of genes from other bacteria. Streptomycin resistance can be caused by either mechanism. A simple mutation (the change of an adenine for
a guanine in codon 43 of the rpsL gene) prevents streptomycin from binding to the ribosome, making the cell resistant to this antibiotic. A number of factors can influence the frequency of such mutations, including the concentration of antibiotic used. For example, mutation leading to kasugamycin resistance in the plant pathogenic bacterium Erwinia amylovora occurred in the laboratory only when using less than 100 ppm of the antibiotic.
Bacteria can acquire genes by several mechanisms which are collectively called horizontal gene transfer. One of those mechanisms is the transfer between bacterial cells of mobile genetic elements called plasmids or transposons. Horizontal gene transfer can also occur by a process known as transduction, in which DNA is introduced to the cell by a bacteriophage, which is a virus which infects and replicates within bacteria. A third mechanism known as transformation occurs when free DNA is picked up by bacterial cells. Resistance to streptomycin in plant pathogenic bacteria has been associated with the acquisition of the genes strA and strB. These genes are already naturally present in plasmids and transposons of bacteria isolated in New Zealand. Genes that confer tolerance to copper have been also been found to be carried by similar mobile genetic elements.
Unlike antibiotics, copper is necessary for bacteria to survive; bacteria can never become resistant to copper, only tolerant. Tolerance to copper is usually the result of several enzymes exporting excess copper to the outside of the cell.
The problem of resistance is compounded by the possibility of cross resistance or multiple resistance. Cross resistance occurs when one event (a mutation or acquisition of new genes) leads to resistance to several antibiotics. This is often observed for antibiotics that share the same target. However, this is not always the case. For example, streptomycin and kasugamycin affect the ribosome but they affect different parts of it. Up until now no mutation has been found that confers resistance to both antibiotics. Similarly, no gene or set of genes has been identified that would confer resistance to both. However, we cannot rule out that a bacterium could become resistant to both of these antibiotics by a mechanism which has not yet been found. Likewise, no gene or mutation which in Pseudomonas would confer resistance to both kasugamycin and copper, or to streptomycin and copper, has been identified today.
Even if the risk of cross resistance between streptomycin, kasugamycin and copper seems very low, there is still the risk that bacteria become resistant to these products by a process of multiple resistance. Multiple resistance is the accumulation of mutations or of genes or set of genes which individually confer resistance to only one compound. Those genes can jump from one piece of DNA to another, resulting in DNA molecules, such as genetic mobile elements, carrying resistance to several compounds. This was the case for strains of Psa isolated in Japan in 1987, which were resistant to streptomycin and copper.
There are only a few strategies available to reduce the probability of selecting strains of Psa that are resistant to the two antibiotics allowed in New Zealand and/or copper. These strategies involve combining and alternating compounds.
By combining compounds, only bacteria which have accumulated either two mutations, or two sets of genes each conferring resistance to one of the compounds used in the combination, will be able to survive. The probability of accumulating two independent mutations each conferring resistance to one compound is extremely low. We do not know the exact rate of mutation of Psa that would lead to antibiotic resistance. But if we estimate it to be around 10-8, then one cell in every 100 million cells could carry a mutation leading to resistance to one antibiotic. Under those conditions, the probability of occurrence of a
strain with two mutations is 10-16, or one cell for every 10,000 trillion cells!
The probability of a strain accumulating two sets of genes conferring antibiotic resistance by horizontal gene transfer is more difficult to estimate. However, by alternating the combinations of products, cells that are resistant to two products will be killed by the next treatment, unless they have also accumulated genes leading to resistance to the new compound used in the combination. Of course the probability of accumulating genes which confer resistance to three compounds is much lower than that of accumulating resistance to two of them.
In addition to those strategies some simple precautions can dramatically reduce the probability of selecting strains of the pathogen resistant or tolerant to one or more antibiotic(s) and/ or copper based products. Independently of whether resistance is total or partial and whether it is due to a mutation or to horizontal
gene transfer, the probability of selecting antibiotic-resistant strains of the pathogen increases with the size of the bacterial population being exposed to the antibiotic, with the duration of the exposure and with the concentration to which the bacteria are being exposed. Therefore, it is extremely important to keep the pathogen population as low as possible using basic orchard hygiene (removing all diseased material from the orchard as soon as practically feasible) and using other compounds which have been shown to reduce infection (elicitors for example). Also, it is not advisable to use less than the recommended rate of antibiotic. Low rates of antibiotic can increase the rate of mutation leading to antibiotic resistance as demonstrated for resistance to kasugamycin in E. amylovora. In addition, the same compound or same combination of compounds should not be applied twice in a row and the number of applications should be limited. Alternating compounds or mixtures of compounds prevents the pathogen from being exposed for too long to the same compound(s). However, bacteria can easily move from one orchard block to another, and spraying two adjacent blocks with the same antibiotic a few days apart can result in some bacteria being subjected to this antibiotic for a much longer period of time than anticipated. This increases the likelihood of selecting antibiotic-resistant bacteria. Therefore, a coordinated control strategy applied on a large scale is more effective than one applied independently on a small scale.
We need to use antibiotics and copper-based products wisely so that we can prevent or delay the selection of Psa strains resistant to these antibacterial compounds, and thus so New Zealand can remain a country where the use of antibiotic for control of plant pathogenic bacteria is authorised and effective.

 

Ploidy - why it's important

Ploidy is a term used to describe the number of sets of chromosomes in the cells of an organism.

Growing big Hayward crops with high dry matter

The 2013 season was a year of extremes in the Bay of Plenty. Some Hayward growers suffered as a result of bud drop or frost damage but others harvested bumper crops and enjoyed an excellent growing season. These top performers demonstrated it is possible to achieve high yields without compromising dry matter in a Psa environment. In this article, we discuss how two orchardists - one conventional and one organic - achieved an excellent result in 2013.

Trialing the use of pollen dispensers

Trialing the use of pollen dispensers

A trial of pollen dispensers fitted to beehives was carried out last season to determine if they would be a useful addition to the tools available for growers to manage their pollination. The dispensers were able to place enough pollen onto bees leaving their hives to achieve full fruit set, and set more than 600 seeds per fruit.

Despite these promising results, with just one trial we can only recommend that, if they are used in the coming season, they are seen as an addition to an orchardist’s current pollination practices rather than a replacement.

Pollination in the presence of Psa

Pollination in the presence of Psa

Psa was detected in low to moderate levels in all milled pollen samples from each of 30 orchards harvested in the Bay of Plenty in November 2012. Work is being undertaken to investigate the possibility of infection of kiwifruit vines via contaminated pollen. All tested samples of commercially produced pollen from Waikato and Bay of Plenty were found to be Psa positive. These results support the approach taken by Kiwifruit Vine Health (KVH) for collecting and applying pollen in the region of origin.
With Pseudomonas syringae pv actinidiae (Psa) present in most of the major kiwifruit growing regions of New Zealand, growers need to review how they manage their vines to optimise production in the presence of this pathogen.
Prior to the arrival of Psa, supplementary pollination, based on commercially milled pollen, was used alongside bee pollination as an important tool to lift orchard productivity.

Pre-harvest thinning: does it pay?

As harvest approaches, many growers or orchard managers will be thinking about the value of doing a final round of pre-harvest thinning. In making this decision, the grower needs to consider a number of issues. These include...

What did we learn from the 2012 winter grafting season?

A comprehensive graft-take survey and a range of grower trials undertaken in 2012 by Zespri‘s Orchard Productivity Centre (OPC) have provided considerable new knowledge around grafting and establishment practices. This includes timing and height of stump cutting, the importance of correct grafting techniques, graft dressings, and nitrogen fertiliser applications post-grafting. This article summarises the key findings...

Daily kiwifruit: the best way to optimum health

Kiwifruit should be eaten daily.

At first glance this statement may seem extreme, so why do we say this?

Our recent research has shown that not all fruits are equal and even a diet with the ‘5+ a day’ component of fruit and vegetables may not deliver the recommended daily intake of vitamin C. In fact, in order to get enough vitamin C to ensure optimum health and disease prevention, the daily diet must contain at least one food that has high vitamin C content. Kiwifruit are one of the best sources of this.

Psa progression within orchards

Since December 2010, a month after Pseudomonas syringae pv. actinidiae (Psa) was first discovered in New Zealand, the development and progression of the disease has been closely monitored in selected kiwifruit orchards. Initially, little was known about how Psa would behave in the New Zealand environment. Through regular and detailed mapping and monitoring of symptom development within canopies, we aimed to determine whether disease incidence increased during the summer, and if leaf symptoms progressed to cane or trunk symptoms. Further aims included determination of carry-over of disease from one season to the next, assessment of relationships between orchard management practices and disease development, and understanding the relationship between disease progression and climatic conditions.